3.5. Clinical Prognostic Significance of the Interpatient Heterogeneity in Selective Reduction of RNAseq-Based CD22 Exon 12 Expression Levels among B-ALL Patients. Here, CD22 is linked to precursor B-cell acute lymphoblastic leukemia.